Benjamin Graham · Defensive deep-value investing
Is Anbio Biotechnology Class A Ordinary Shares (NNNN) a Benjamin Graham Stock?
Meets 3/7 Graham criteria, classic deep-value candidate.
87/100
Fits
3/7 criteria passed
Benjamin Graham's Criteria, Applied to NNNN
P/E ≤ 15
key171.9x
P/B ≤ 1.5
key41.0x
Current ratio ≥ 2
-
Debt / Equity ≤ 1
0.0x
How NNNN Scores on Other Strategies
Live Financial Snapshot
Market cap
$163.28M
P/E (TTM)
171.9x
ROIC (TTM)
21.48%
Gross margin
87.06%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is NNNN's Benjamin Graham fit score?
NNNN scores 87/100 on our Benjamin Graham fit engine. Meets 3/7 Graham criteria, classic deep-value candidate.
Does Benjamin Graham actually own NNNN?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends NNNN.
How often is this score updated?
NNNN's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends NNNN.
